Asensus Surgical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 7 rows in 2022. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-06-14: Reporting owner Hobert Kevin J; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-06-14: Reporting owner Biffi Andrea; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-06-14: Reporting owner Starling William N JR; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-06-14: Reporting owner Milne David Bruce; Form 4; Security Stock Option; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-06-14 | Hobert Kevin J Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,340 55,340 owned after | $0.38 exercise price | 2022-06-15 | |
| 2022-06-14 | Biffi Andrea Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +116,828 116,828 owned after | $0.38 exercise price | 2022-06-15 | |
| 2022-06-14 | Starling William N JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,340 55,340 owned after | $0.38 exercise price | 2022-06-15 | |
| 2022-06-14 | Milne David Bruce Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,340 55,340 owned after | $0.38 exercise price | 2022-06-15 | |
| 2022-06-14 | Kwo Elizabeth Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,340 55,340 owned after | $0.38 exercise price | 2022-06-15 | |
| 2022-02-04 | Shameze Rampertab Officer (EVP, Chief Financial Officer) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +222,500 222,500 owned after | $0.80 exercise price | 2022-02-07 | |
| 2022-02-04 | Fernando Anthony C. J. Director, Officer (President and CEO) | 4 | Stock Options Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +578,000 578,000 owned after | $0.80 exercise price | 2022-02-07 |